Skip to main content
. 2020 Dec;21(12):3587–3593. doi: 10.31557/APJCP.2020.21.12.3587

Table 4.

Univariate Analysis for Overall Survival Comparing Patients with Bone Oligometastasis vs Patients without Any Metastasis

Subtype Hazard Ratio (95% CI) P
HR+/HER2- 7.50 (6.95-8.09) < 0.0001*
HR+/HER2+ 4.61 (3.52-6.03) < 0.0001*
HR-/HER2+ 4.73 (3.40-6.59) < 0.0001*
TNBC 8.85 (7.58-10.34) < 0.0001*

P values were for log-rank tests; * Significant P value (<0.05)